Immunology of malignant ovarian neoplasms. II. Nonspecific immunity and the effect of treatment
Markowska, J.
Ginekologia Polska 56(4): 202-206
1985
ISSN/ISBN: 0017-0011 PMID: 3876262 Document Number: 250490
Document emailed within 1 workday
Related Documents
Grinevich, I.A. 1991: Nonspecific active immunotherapy in the combined treatment of malignant neoplasms Vrachebnoe Delo 5: 8-11Renoux, G.; Renoux, M. 1972: Antigenic competition and nonspecific immunity after a rickettsial infection in mice: restoration of antibacterial immunity by phenyl-imidothiazole treatment Journal of Immunology 109(4): 761-765
Kulinich, S.I.; Seliverstova, L.V.; Shepotinnik, N.L.; Golovina, L.I.; Vasilkova, A.A. 1991: The morbidity of malignant ovarian neoplasms in Irkutsk Province Voprosy Onkologii 37(1): 23-25
Bulbuk, G.A. 1982: Immunity indices of patients with locally disseminated malignant neoplasms of the head and neck Voprosy Onkologii 28(4): 57-59
Pasquinucci, C.; Pittino, R. 1977: Enzymatic and biochemical parameters in the diagnosis of malignant ovarian neoplasms Minerva Ginecologica 29(5): 411-418
Dement'eva, M.P. 1974: Effect of cardiogenic shock in myocardial infarction on the state of nonspecific immunity Sovetskaia Meditsina 9: 136-137
Rudenko, L.G.; Selivanov, A.A.; Ikramov, N.V.; Tsybul'skaia, N.V.; Ostrovskiĭ, A.D. 1984: Effect of repeated immunization with inactivated influenza vaccine on the formation of specific and nonspecific immunity factors Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 12: 98-101
Czekierdowski, A. 2002: Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 57(1): 113-131
Levina, E.N.; Frolov, V.M.; Shuster, M.A.; Savitskaia, K.I.; Iurina, T.M. 1981: Characteristics of the immunity and nonspecific reactivity indices in chronic suppurative mesotympanitis in the treatment with hyperimmune plasmas Vestnik Otorinolaringologii 5: 18-20
Beliaev, S.E. 1974: State of certain indicators of natural nonspecific immunity in children with rheumatism during continuous bicillin prophylactic treatment Pediatriia 53(4): 63
Petersson, B.H. 1993: Ovarian neoplasms and treatment of infertility Ugeskrift for Laeger 155(26): 2065-2066
Cabrera, J.; Fluxá, L.; Pérez, C.; Ramírez, I.; Toledo, P.; Poloni, O. 1993: Effect of preoperative brachytherapy on estrogenic ovarian function, in patients with cervical neoplasms Revista Chilena de Obstetricia y Ginecologia 58(3): 220-227
Komorowska, A.; Palińska-Weese, Z. 1978: Treatment of cases of ovarian neoplasms in girls and adolescents Ginekologia Polska 49(5): 411-415
Baksheev, N.S.; Milianovskiĭ, A.I.; Dudarenko, V.P.; Frolova, G.D.; Kolesnik, L.N. 1975: Serotonin in complex treatment of uterine and ovarian neoplasms Akusherstvo i Ginekologiia 8: 47-51
Pittermann, E.; Stacher, A.; Griendl, W. 1974: Effect of a new cytostatic agent (peptichemio) on malignant neoplasms Wiener Medizinische Wochenschrift 124(14): 216
Catania, G.; Basile, F.; Cardi, F.; Azzarello, G.; Di Stefano, A.; Messina, L.; Giovinetto, A. 1981: Effect of methisoprinol on postoperative immunodepression in subjects with malignant neoplasms Minerva Medica 72(9): 569-573
Worse-Petersen, J. 1970: Treatment of pain in malignant neoplasms Nordisk Medicin 84(33): 1053
Orłowski, T.M.; Budzyński, W. 1981: Hyperthermia in the treatment of malignant neoplasms Wiadomosci Lekarskie 34(10): 831-833
Robak, T.; Drzewoski, J. 1990: Treatment of malignant neoplasms in pregnancy. II Przeglad Lekarski 47(8): 603-606
Abu-Jawdeh, G.M.; Faix, J.D.; Niloff, J.; Tognazzi, K.; Manseau, E.; Dvorak, H.F.; Brown, L.F. 1996: Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms Laboratory Investigation; A Journal of Technical Methods and Pathology 74(6): 1105-1115